Literature DB >> 17070115

Quantification of isoniazid and acetylisoniazid in rat plasma and alveolar macrophages by liquid chromatography-tandem mass spectrometry with on-line extraction.

Ka-yun Ng1, Huiyu Zhou, Yan Ling Zhang, Brooks Hybertson, Theodore Randolph, Uwe Christians.   

Abstract

To evaluate if pulmonary delivery of microparticles loaded with a prodrug of isoniazid (INH), isoniazid methanesulfonate (INHMS), can target alveolar macrophages (AM) and reduce metabolism of INH, an HPLC-MS/MS assay with automated online extraction for quantification of INH and its metabolite acetylisoniazid (AcINH) in plasma and AMs was developed and validated. Reproducibility in rat plasma and homogenate of a rat AM cell line, NR8383, for INH and AcINH showed excellent precision and accuracy with calibration curves exhibiting linearity within a range of 1-250ng/ml of INH and 0.05-50ng/ml of AcINH (r(2)>0.99). The validated methods were successfully applied to pharmacokinetic study of INHMS-loaded microparticles in rats, demonstrating efficient targeting of AMs and reduction of INH metabolism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070115     DOI: 10.1016/j.jchromb.2006.10.008

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Reagent precoated targets for rapid in-tissue derivatization of the anti-tuberculosis drug isoniazid followed by MALDI imaging mass spectrometry.

Authors:  M Lisa Manier; Michelle L Reyzer; Anne Goh; Veronique Dartois; Laura E Via; Clifton E Barry; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2011-05-13       Impact factor: 3.109

2.  Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for determination of isoniazid in human plasma.

Authors:  Liusheng Huang; Florence Marzan; Anura L Jayewardene; Patricia S Lizak; Xiaohua Li; Francesca T Aweeka
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-12-24       Impact factor: 3.205

3.  Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.

Authors:  A Toure; M Cabral; A Niang; C Diop; A Garat; L Humbert; M Fall; A Diouf; F Broly; M Lhermitte; D Allorge
Journal:  Toxicol Rep       Date:  2016-10-17

4.  Development of a Nafion/MWCNT-SPCE-Based Portable Sensor for the Voltammetric Analysis of the Anti-Tuberculosis Drug Ethambutol.

Authors:  Rosa A S Couto; Maria Beatriz Quinaz
Journal:  Sensors (Basel)       Date:  2016-06-30       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.